What's new

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

Open

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Open

Quotes from 3rd VAM conference

3 June 2020

Quote

Read more

Physicians recognised potential of Value Added Medicines

3 June 2020

Infographic

Open

Questions and answers on regulatory expectations for medicinal products for human use during the COVID-19 pandemic

10 April 2020

External Resource

Open

Perceptions and recommendations of physicians/KOLs on value added medicines

21 November 2019

Report

Open

The secret to improve access to value added medicines

14 November 2019

Policy

Open

Improving healthcare delivery in hospitals by optimized utilization of medicines

7 October 2019

Report

Open

A digital future for value added medicines

24 September 2019

Policy, Report

Open

How can your healthcare system support a wider access to Value Added Medicines?

27 May 2019

Infographic

Open

Subscribe to our newsletter